Valuation: Bio-Rad Laboratories, Inc.

Market Cap 10.25B 9.01B 8.5B 7.75B 14.5B 984B 14.61B 102B 39.52B 501B 38.48B 37.64B 1,629B P/E 2026 *
46.6x
P/E 2027 * 45.5x
Enterprise Value 9.5B 8.36B 7.88B 7.19B 13.44B 912B 13.54B 94.52B 36.63B 464B 35.67B 34.89B 1,510B EV / Sales 2026 *
3.69x
EV / Sales 2027 * 3.53x
Free-Float
60.17%
Yield 2026 *
-
Yield 2027 * -
1 day+2.29%
1 week+1.34%
Current month+0.37%
1 month+1.51%
3 months+38.38%
6 months+42.42%
Current year+27.91%
1 week 373.47
Extreme 373.47
389.38
1 month 365.66
Extreme 365.66
396.23
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
798.97
10 years 154.89
Extreme 154.89
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
9/6/26 Exercice

General Counsel

1,841 0.0085%
9/6/26 Exercice

Chief Executive Officer

8,764 0.0404%
9/6/26 Exercice

Chief Financial Officer

3,854 0.0178%
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%+1.34%+40.10%+9.78% 10.06B
-2.34%-1.13%-24.51%+2.98% 179B
-0.88%-4.59%-7.55%+10.27% 114B
-0.77%+0.15%+0.49%+66.64% 59.59B
-1.80%-1.19%-3.67%-32.42% 49.72B
+0.97%+3.47%+13.27%+51.69% 47.75B
-0.30%-0.52%+29.59%-0.03% 33.11B
+1.05%+7.91% - - 30.09B
-0.60%+1.91%+43.73%+0.29% 26.45B
+4.96%+10.05%+19.03%-6.09% 22.79B
Average +0.27%+1.55%+12.27%+11.45% 57.29B
Weighted average by Cap. -0.81%-0.40%-3.31%+11.97%

Financials

2026 *2027 *
Net sales 2.57B 2.26B 2.13B 1.95B 3.64B 247B 3.67B 25.6B 9.92B 126B 9.66B 9.45B 409B 2.63B 2.32B 2.18B 1.99B 3.73B 253B 3.75B 26.2B 10.15B 129B 9.89B 9.67B 419B
Net income 225M 198M 186M 170M 318M 21.58B 321M 2.24B 867M 10.98B 844M 826M 35.75B 230M 202M 190M 174M 325M 22.05B 328M 2.29B 886M 11.22B 862M 844M 36.52B
Net Debt -749M -659M -621M -567M -1.06B -71.9B -1.07B -7.45B -2.89B -36.59B -2.81B -2.75B -119B -965M -849M -801M -730M -1.37B -92.67B -1.38B -9.61B -3.72B -47.17B -3.62B -3.55B -153B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-09-24 $387.54 +2.29% 374,174
26-09-23 $378.88 -0.18% 177,213
26-09-22 $379.57 +0.59% 374,684
26-09-21 $377.33 +0.24% 311,465
26-09-18 $376.41 -1.57% 324,347
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
387.54USD
Average target price
329.00USD
Spread / Average Target
-15.11%

Quarterly revenue - Rate of surprise